Cantel Medical Quick Ratio (CMD) starting from the third quarter 2021 to third quarter 2020, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Cantel Medical Corp   (NYSE: CMD)

Cantel Medical 's Quick Ratio

CMD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2021, Quick Ratio fell to 0.9 above Cantel Medical Corp average.

Within Medical Equipment & Supplies industry 151 other companies have achieved higher Quick Ratio than Cantel Medical in third quarter 2021. While Quick Ratio total ranking in the third quarter 2021 has deteriorated compared to the prior quarter from 2347 to 2611.

Explain Quick Ratio?
How much Cash & cash equivalents CMD´s has?
What are CMD´s Current Liabilities?




CMD Quick Ratio (Apr 30 2021)
Q3
(Jan 31 2021)
Q2
(Oct 31 2020)
Q1
(Jul 31 2020)
Q4
(Apr 30 2020)
Q3
Y / Y Current Liabilities Change 22.74 % 14.98 % 9.17 % 11.78 % 59.07 %
Y / Y Cash & cash equivalent Change 88.77 % 313.86 % 423.53 % 523.94 % 125.45 %
Quick Ratio MRQ 0.9 1.04 1.29 1.64 0.58
CMD's Total Ranking # 2611 # 2347 # 1433 # 1414 # 3124
Seq. Current Liabilities Change 3.58 % 17.15 % 18.31 % -14.5 % -2.97 %
Seq. Cash & cash equivalent Change -10.09 % -5.8 % -7.14 % 140.03 % 97.12 %



Quick Ratio third quarter 2021 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 152
Healthcare Sector # 869
Overall Market # 2611


Quick Ratio Statistics
High Average Low
1.64 0.51 0.26
(Jul 31 2020)   (Jan 31 2017)




Financial Statements
Cantel Medical 's Current Liabilities $ 243 Millions Visit CMD's Balance sheet
Cantel Medical 's Cash & cash equivalent $ 219 Millions Visit CMD's Balance sheet
Source of CMD's Sales Visit CMD's Sales by Geography


Cumulative Cantel Medical 's Quick Ratio

CMD's Quick Ratio for the trailling 12 Months

CMD Quick Ratio

(Apr 30 2021)
12 Months
(Jan 31 2021)
12 Months
(Oct 31 2020)
12 Months
(Jul 31 2020)
12 Months
(Apr 30 2020)
12 Months
Y / Y Current Liabilities TTM Growth 14.96 % 20.91 % 39.05 % 55.3 % 57.94 %
Y / Y Cash & cash equivalent TTM Growth 271.76 % 338.81 % 228.58 % 117.22 % -4.35 %
Quick Ratio TTM 1.18 1.12 0.92 0.66 0.36
Total Ranking TTM # 4905 # 4905 # 1974 # 1671 # 5026
Seq. Current Liabilities TTM Growth 5.61 % 3.96 % 2.23 % 2.42 % 11.08 %
Seq. Cash & cash equivalent TTM Growth 11.49 % 25.95 % 41.61 % 86.96 % 31.59 %


On the trailing twelve months basis CMD Cash & cash equivalent soared by 88.77 % in Q3 2021 year on year, faster than Current Liabilities, this led to increase in in Cantel Medical 's Quick Ratio to 1.18, above CMD average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 201 other companies have achieved higher Quick Ratio than Cantel Medical . While overall ranking is unchanged compared to the previous 12 months at no. 4905.

Explain Quick Ratio?
How much Cash & cash equivalents CMD´s has?
What are CMD´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 202
Healthcare Sector # 1006
Within the Market # 4905


trailing twelve months Quick Ratio Statistics
High Average Low
1.16 0.47 0.28
(Apr 30 2021)   (Jan 31 2017)




Companies with similar Quick Ratio in the quarter ending Apr 30 2021, within Medical Equipment & Supplies Industry Quick RatioApr 30 2021 MRQ Cash & cash equivalentApr 30 2021 MRQ Current Liabilities
Neurometrix Inc   2.46 $ 5.145  Millions$ 2.088  Millions
Tactile Systems Technology Inc   2.46 $ 46.925  Millions$ 19.114  Millions
Cerus Corporation  2.41 $ 131.725  Millions$ 54.764  Millions
Polypid Ltd  2.37 $ 9.819  Millions$ 4.136  Millions
Invo Fertility Inc   2.36 $ 8.423  Millions$ 3.564  Millions
Harpoon Therapeutics Inc   2.34 $ 229.413  Millions$ 98.163  Millions
Seaspine Holdings Corporation  2.20 $ 87.749  Millions$ 39.928  Millions
Penumbra Inc  2.17 $ 242.609  Millions$ 111.862  Millions
Logicmark Inc  2.09 $ 8.516  Millions$ 4.068  Millions
Orthopediatrics Corp  2.09 $ 76.635  Millions$ 36.623  Millions
Universal Biosensors Inc   2.07 $ 15.766  Millions$ 7.618  Millions
Anika Therapeutics Inc   2.01 $ 94.599  Millions$ 46.973  Millions
Marizyme Inc   1.94 $ 0.865  Millions$ 0.445  Millions
Pear Therapeutics Inc   1.89 $ 0.749  Millions$ 0.397  Millions
Brainsway Ltd   1.87 $ 16.921  Millions$ 9.067  Millions
Globus Medical Inc   1.77 $ 218.711  Millions$ 123.677  Millions
Plus Therapeutics Inc   1.76 $ 14.447  Millions$ 8.202  Millions
Nu med Plus Inc   1.64 $ 0.139  Millions$ 0.085  Millions
Intersect Ent Inc   1.62 $ 70.524  Millions$ 43.538  Millions
Mimedx Group Inc   1.53 $ 84.746  Millions$ 55.411  Millions
Ufp Technologies Inc   1.52 $ 25.377  Millions$ 16.668  Millions
Sharecare Inc   1.44 $ 0.325  Millions$ 0.226  Millions
Genedx Holdings Corp   1.39 $ 58.652  Millions$ 42.102  Millions
Edwards Lifesciences Corporation  1.35 $ 1,330.600  Millions$ 987.800  Millions
Nexgel Inc   1.33 $ 1.070  Millions$ 0.803  Millions
Steris Plc  1.31 $ 220.531  Millions$ 168.651  Millions
National Vision Holdings Inc   1.26 $ 453.792  Millions$ 359.828  Millions
Dexcom Inc   1.26 $ 733.800  Millions$ 584.000  Millions
Encision Inc   1.25 $ 1.474  Millions$ 1.176  Millions
Yubo International Biotech Limited  1.25 $ 0.304  Millions$ 0.244  Millions

Date modified: 2026-09-08T15:10:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.